The molecular mechanism (a) leads to elevations in serum leptin concentrations in CKD patients, and (b) harmful effects of hyperleptinemia on kidney function and associated diseases seem to be complex and need to be further explained. The gene discussed is LEP; the disease is chronic kidney disease.